A fusion protein blocking activin receptor signalling, studied for dramatic effects on muscle mass and bone density.
A single-chain relaxin analogue studied for anti-fibrotic activity and tissue remodelling research.
A premium triple-peptide healing and regeneration blend combining repair, recovery, and anti-aging mechanisms.
The most popular recovery research blend — combining BPC-157 and TB-500 for comprehensive tissue repair studies.
Double-strength BPC-157 vial for extended healing and cytoprotection research protocols.
GHRH analogue paired with one of the most potent GH-releasing peptides for robust GH axis research.
A synergistic GHRH and GHRP research blend offering complementary GH stimulation via two independent pathways.
A long-acting GHRH analogue with Drug Affinity Complex technology enabling prolonged GH stimulation in research models.
A short-acting GHRH analogue producing pulsatile GH release, ideal for physiological GH axis research.
A triple GH-axis research blend combining GHRH and two complementary GH secretagogues.
One of the most potent growth hormone-releasing peptides, studied for GH secretion, appetite stimulation, and recovery.
Nexopep’s premium triple regeneration blend combining repair, copper peptide renewal, and systemic recovery in one vial.
A potent synthetic GHRP studied for both GH release and direct cardiovascular and tissue-protective effects.
A truncated IGF-1 variant with enhanced receptor binding potency studied for local tissue proliferation and repair.
A long-acting IGF-1 analogue with extended half-life studied for muscle growth, cell proliferation, and metabolic signalling.
